WO1996023489A2 - Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen - Google Patents
Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen Download PDFInfo
- Publication number
- WO1996023489A2 WO1996023489A2 PCT/EP1996/000381 EP9600381W WO9623489A2 WO 1996023489 A2 WO1996023489 A2 WO 1996023489A2 EP 9600381 W EP9600381 W EP 9600381W WO 9623489 A2 WO9623489 A2 WO 9623489A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- carotenoids
- carotene
- minutes
- histamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Definitions
- Reactive oxygen species or singlet oxygen most likely play an important role in the pathogenesis of various allergic and non-allergic inflammations. It is also suspected that such species are involved in the degranular tion with release of mediators from mast cells. What is certain is that degranulation of the mast cells and the basophilic granulocytes in the blood is the first step in the initiation of an allergic reaction.
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96902950A EP0806946A2 (de) | 1995-02-03 | 1996-02-02 | Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen |
AU47157/96A AU4715796A (en) | 1995-02-03 | 1996-02-02 | Use of carotinoids for preparing medicaments for treating dermatoses |
US08/875,622 US5886053A (en) | 1995-02-03 | 1996-02-02 | Use of carotenoids for producing drugs for the treatment of dermatoses |
JP8523252A JPH10513444A (ja) | 1995-02-03 | 1996-02-02 | 皮膚疾患の治療のための医薬品の製造のためのカロチノイドの使用 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1995103604 DE19503604A1 (de) | 1995-02-03 | 1995-02-03 | Verwendung von Carotinoiden zur Herstellung von Arzneimitteln zur Behandlung von Dermatosen |
DE19503604.2 | 1995-02-03 | ||
DE1995139743 DE19539743A1 (de) | 1995-10-25 | 1995-10-25 | Verwendung von Carotinoiden zur Herstellung von Arzneimitteln zur Behandlung von entzündlichen Erkrankungen |
DE19539743.6 | 1995-10-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996023489A2 true WO1996023489A2 (de) | 1996-08-08 |
WO1996023489A3 WO1996023489A3 (de) | 1996-10-03 |
Family
ID=26012140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1996/000381 WO1996023489A2 (de) | 1995-02-03 | 1996-02-02 | Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen |
Country Status (6)
Country | Link |
---|---|
US (1) | US5886053A (de) |
EP (1) | EP0806946A2 (de) |
JP (1) | JPH10513444A (de) |
AU (1) | AU4715796A (de) |
CA (1) | CA2210957A1 (de) |
WO (1) | WO1996023489A2 (de) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998037874A1 (en) * | 1997-02-27 | 1998-09-03 | Astacarotene Ab | Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection |
WO1999011251A1 (en) * | 1997-09-04 | 1999-03-11 | Astacarotene Ab | Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases |
WO1999030701A1 (en) * | 1997-12-16 | 1999-06-24 | Astacarotene Ab | Method of the prophylactic treatment of mastitis |
WO2000023064A1 (en) * | 1998-10-16 | 2000-04-27 | Astacarotene Ab | Treatment of dyspepsia |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19653410A1 (de) * | 1996-12-20 | 1998-06-25 | Basf Ag | Verwendung von Carotinoid-Solubilisaten zum Färben von Lebensmitteln und pharmazeutischen Zubereitungen |
WO1998045241A2 (en) | 1997-04-04 | 1998-10-15 | Henkel Corporation | Lutein esters having high bioavailability |
SE9903619D0 (sv) * | 1999-10-07 | 1999-10-07 | Astacarotene Ab | Use and method of treatment |
SE0001071D0 (sv) * | 2000-03-27 | 2000-03-27 | Astacarotene Ab | Method of inhibiting the expression of inflammatory cytokines and chemokines |
US7078040B2 (en) * | 2000-03-27 | 2006-07-18 | Fuji Chemical Industry Co., Ltd. | Method of inhibiting the expression of inflammatory cytokines and chemokines |
DE10221212A1 (de) * | 2002-05-13 | 2003-11-27 | Andreas Maack | Sporopollenin enthaltende lösliche Zusammensetzung und Verwendung |
US7723327B2 (en) * | 2002-07-29 | 2010-05-25 | Cardax Pharmaceuticals, Inc. | Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
US20050049248A1 (en) * | 2002-07-29 | 2005-03-03 | Lockwood Samuel Fournier | Carotenoid ether analogs or derivatives for controlling C-reactive protein levels |
US7375133B2 (en) * | 2002-07-29 | 2008-05-20 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US20050026874A1 (en) * | 2002-07-29 | 2005-02-03 | Lockwood Samuel Fournier | Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease |
US20050143475A1 (en) * | 2002-07-29 | 2005-06-30 | Lockwood Samuel F. | Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
US20050059635A1 (en) * | 2002-07-29 | 2005-03-17 | Lockwood Samuel Fournier | Carotenoid ester analogs or derivatives for controlling C-reactive protein levels |
US20050009788A1 (en) * | 2002-07-29 | 2005-01-13 | Lockwood Samuel Fournier | Carotenoid ester analogs or derivatives for controlling connexin 43 expression |
US7521584B2 (en) * | 2002-07-29 | 2009-04-21 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of disease |
CN1708480B (zh) * | 2002-07-29 | 2010-12-15 | 卡达克斯药物公司 | 用于抑制和改善疾病的类胡萝卜素结构类似物 |
US20050059659A1 (en) * | 2002-07-29 | 2005-03-17 | Lockwood Samuel Fournier | Carotenoid analogs or derivatives for controlling C-reactive protein levels |
US7320997B2 (en) * | 2002-07-29 | 2008-01-22 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
US20050148517A1 (en) * | 2002-07-29 | 2005-07-07 | Lockwood Samuel F. | Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
US7345091B2 (en) * | 2002-07-29 | 2008-03-18 | Cardax Pharmaceuticals, Inc. | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US20050004235A1 (en) * | 2002-07-29 | 2005-01-06 | Lockwood Samuel Fournier | Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease |
US7763649B2 (en) * | 2002-07-29 | 2010-07-27 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for controlling connexin 43 expression |
JP3780236B2 (ja) * | 2002-08-07 | 2006-05-31 | キヤノン株式会社 | ガスが浸透した材料の保管方法 |
JP2006503194A (ja) * | 2002-10-18 | 2006-01-26 | コーロン インダストリーズ インク | 微細多孔質繊維及びその製造方法 |
EP1750723A1 (de) * | 2004-04-14 | 2007-02-14 | Hawaii Biotech, Inc. | Carotenoid-analoga oder derivate zur hemmung und linderung von entzündungen |
US20060058269A1 (en) * | 2004-04-14 | 2006-03-16 | Lockwood Samuel F | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
US7351424B2 (en) * | 2004-07-22 | 2008-04-01 | Bio Lut S.A. De C.V. | Enhanced purity trans-lutein-ester compositions and methods of making same |
US20060269497A1 (en) * | 2005-05-27 | 2006-11-30 | Yamaha Hatsudoki Kabushiki Kaisha | Trichogenous agent |
FR2935610B1 (fr) * | 2008-09-05 | 2010-10-29 | Lvmh Rech | Composition cosmetique ou dermatologique contenant un melange d'huiles essentielles et son utilisation, notamment pour le soin des peaux sensibles ou sensibilisees |
TWI492744B (zh) * | 2009-12-04 | 2015-07-21 | Abbott Lab | 使用類胡蘿蔔素調節早產兒發炎症之方法 |
US9034342B2 (en) * | 2010-03-25 | 2015-05-19 | Gateway Health Alliances, Inc | Methods and compositions to reduce fat gain, promote weight loss in animals |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0542632A1 (de) * | 1991-11-14 | 1993-05-19 | LABORATOIRES ARKOPHARMA Société Anonyme | Verwendung von Beta-Karotin zur Behandlung von Asthma |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2591105B1 (fr) * | 1985-12-11 | 1989-03-24 | Moet Hennessy Rech | Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide. |
DE4031094A1 (de) * | 1990-10-02 | 1992-04-09 | Basf Ag | Verfahren zur herstellung von stabilen injizierbaren (beta)-carotin-solubilisaten |
-
1996
- 1996-02-02 US US08/875,622 patent/US5886053A/en not_active Expired - Fee Related
- 1996-02-02 JP JP8523252A patent/JPH10513444A/ja active Pending
- 1996-02-02 EP EP96902950A patent/EP0806946A2/de not_active Withdrawn
- 1996-02-02 AU AU47157/96A patent/AU4715796A/en not_active Abandoned
- 1996-02-02 WO PCT/EP1996/000381 patent/WO1996023489A2/de not_active Application Discontinuation
- 1996-02-02 CA CA002210957A patent/CA2210957A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0542632A1 (de) * | 1991-11-14 | 1993-05-19 | LABORATOIRES ARKOPHARMA Société Anonyme | Verwendung von Beta-Karotin zur Behandlung von Asthma |
Non-Patent Citations (8)
Title |
---|
9TH CONGRESS OF THE EUROPEAN SOCIETY OF PARENTERAL AND ENTERAL NUTRITION, BARCELONA, SPAIN, SEPTEMBER 13-16, 1987. CLIN NUTR (EDINB), 6 (SPEC. SUPPL.). 1987. 36., XP000577901 ABAD-LACRUZ A ET AL: "PLASMA VITAMINS A AND E IN HOSPITALIZED PATIENTS WITH INFLAMMATORY BOWEL DISEASE IBD" * |
9TH CONGRESS OF THE EUROPEAN SOCIETY OF PARENTERAL AND ENTERAL NUTRITION, BARCELONA, SPAIN, SEPTEMBER 13-16, 1987. CLIN NUTR (EDINB), 6 (SPEC. SUPPL.). 1987. 70., XP000577902 GONZALEZ-HUIX F ET AL: "VITAMIN STATUS IN PATIENTS WITH CROHN'S DISEASE CD" * |
ANN. DERMATOL. VENEREOL., 1991, 118/11 (824-825), FRANCE, XP000578412 OBERLIN P. ET AL: "Amicrobial pustulosis and systemic lupus erythematosus" * |
AUST N Z J OPHTHALMOL, FEB 1995, 23 (1) P3-7, AUSTRALIA, XP000577875 FLORENCE TM: "The role of free radicals in disease." * |
GASTROENTEROLOGY, 106 (4 SUPPL.). 1994. A768., XP000577983 SCHEURLEN C ET AL: "Endogenous antioxidant status in inactive Crohn's disease complicated by intestinal strictures and fistulae" * |
INFLAMMATION RESEARCH, 45 (SUPPL. 1). 1996. S5-S6., XP000577938 BOLSMANN K ET AL: "Histamine release from mast cells and monocytes: The effects of azelastine, reproterol and vitamin A-analogues" * |
NOUV. PRESSE MED., 1981, 10/23 (1938), FRANCE, XP000578401 FRANCESCHINI PH. ET AL: "Treatment of lupus erythematosus and photosensitive dermatoses with carotenoids" * |
Z. HAUTKR., 1990, 65/1 (17-27), GERMANY, FEDERAL REPUBLIC OF, XP000577984 LAWLOR F. ET AL: "Exploration of new therapeutic strategies in urticaria as a result of clinically orientated research" * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998037874A1 (en) * | 1997-02-27 | 1998-09-03 | Astacarotene Ab | Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection |
US6262316B1 (en) | 1997-02-27 | 2001-07-17 | Astacarotene Ab | Oral preparation for the prophylactic and therapeutic treatment of Helicobacter sp. infection |
WO1999011251A1 (en) * | 1997-09-04 | 1999-03-11 | Astacarotene Ab | Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases |
US6245818B1 (en) | 1997-09-04 | 2001-06-12 | Astacarotene Ab | Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases |
WO1999030701A1 (en) * | 1997-12-16 | 1999-06-24 | Astacarotene Ab | Method of the prophylactic treatment of mastitis |
US6335015B1 (en) | 1997-12-16 | 2002-01-01 | Astacarotene Ab | Method of the prophylactic treatment of mastitis |
WO2000023064A1 (en) * | 1998-10-16 | 2000-04-27 | Astacarotene Ab | Treatment of dyspepsia |
US6923967B1 (en) | 1998-10-16 | 2005-08-02 | Astacarotene Ab | Treatment of dyspepsia |
Also Published As
Publication number | Publication date |
---|---|
EP0806946A2 (de) | 1997-11-19 |
US5886053A (en) | 1999-03-23 |
JPH10513444A (ja) | 1998-12-22 |
WO1996023489A3 (de) | 1996-10-03 |
AU4715796A (en) | 1996-08-21 |
CA2210957A1 (en) | 1996-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996023489A2 (de) | Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen | |
EP2192911B1 (de) | Pflanzenextrakt aus thc-armen cannabis zur behandlung von erkrankungen | |
DE69735814T2 (de) | Verwendung von komplexen in die herstellung von präparaten zur behandlung empfindlicher haut, verfahren zur herstellung und hypoallergenische präparate | |
DE69822546T2 (de) | Kosmetische oder pharmazeutische Zusammensetzung, die ein Kulturmedium eines Mikroorganismus enthält | |
DE69004081T2 (de) | Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen. | |
WO1994001089A1 (de) | Liposomen, verfahren zu ihrer herstellung und ihre verwendung zur herstellung eines arzneimittels | |
DE69818806T2 (de) | Antimikrobielle kosmetische präparate | |
AT392732B (de) | Hautregenerierende und hydratisierende kosmetische mittel sowie ein verfahren zu deren herstellung | |
DE4106026C2 (de) | ||
CN112006970B (zh) | 一种抗瘙痒功效组合物及其制备方法与应用 | |
DE60128238T2 (de) | Antiallergische verbindungen und diese enthaltende medikamente, nahrungsmittel, getränke oder kosmetika sowie verfahren zu deren herstellung | |
DE3936328A1 (de) | Pharmazeutische praeparate | |
EP0201053B1 (de) | Verwendung von Pollenextrakten zur Herstellung von pharmazeutischen Präparaten zur prophylaktischen Behandlung von Allergien | |
DE69814058T2 (de) | Neue Salicylsäurederivate und ihre Verwendung in kosmetischen oder dermatologischen Zusammensetzung | |
EP3795163A1 (de) | Topische pflanzenextraktformulierung enhaltend urtica dioica und vitamin a | |
DE3809801A1 (de) | Kosmetische lichtschutzpraeparate und verfahren zu ihrer herstellung | |
DE19539743A1 (de) | Verwendung von Carotinoiden zur Herstellung von Arzneimitteln zur Behandlung von entzündlichen Erkrankungen | |
DE69018570T2 (de) | Wasserlösliche Vitamin A-Zubereitungen und deren Verwendung bei der Hautbehandlung. | |
DE19503604A1 (de) | Verwendung von Carotinoiden zur Herstellung von Arzneimitteln zur Behandlung von Dermatosen | |
EP2877153B1 (de) | Vitaminzubereitung | |
DE1667890C3 (de) | Dermatologische und kosmetische äußerlich anzuwendende Mittel zur Be handlung von Hautkollagenosen | |
EP0010208A1 (de) | Pharmazeutisches Mittel, enthaltend all-E- oder 13-Z-7,8-Dehydro-Retinsäure und Verfahren zu seiner Herstellung | |
EP1131101B1 (de) | Khellin-zubereitung und deren verwendung zur topischen therapie | |
US5091522A (en) | Retinoic esters of d-desosamine, process for their preparation and their use in human or veterinary medicine and in cosmetic compositions | |
CH690023A5 (de) | Mittel zur Behandlung krankhafter Zellveränderungen der Nasenschleimhaut. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996902950 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08875622 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2210957 Country of ref document: CA Ref country code: CA Ref document number: 2210957 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1996 523252 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1996902950 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996902950 Country of ref document: EP |